Danniell Hicks
Nurse Practitioner · Greenwood, DENPI 1649847583
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 304 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 42 manufacturers reported payments, led by Novo Nordisk at 24.4% of the total. 2025 is the largest year on record at $2,555, 3.1 times the $819 reported in 2022. Among nurse practitioner clinicians in DE with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 304 payments — averaging $20.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$2K
- Insulet Corporation$791
- Lilly USA, LLC$576
- Mallinckrodt Hospital Products Inc.$329
- Xeris Pharmaceuticals, Inc.$320
- AbbVie$238
- plus $3K from 36 others
What the payments were for
- Food & beverage$6,283100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 86 | $1,537 |
| Insulet Corporation | 42 | $791 |
| Lilly USA, LLC | 31 | $576 |
| Mallinckrodt Hospital Products Inc. | 12 | $329 |
| Xeris Pharmaceuticals, Inc. | 11 | $320 |
| AbbVie | 12 | $238 |
| Sanofi-aventis U.S. LLC | 10 | $183 |
| Dexcom, Inc. | 6 | $180 |
| AstraZeneca(2 entities) | 10 | $170 |
| Boehringer Ingelheim | 9 | $166 |
| Phathom Pharmaceuticals, Inc. | 4 | $162 |
| Eisai Inc. | 8 | $162 |
| Lundbeck LLC | 5 | $134 |
| Viiv Healthcare Company | 1 | $122 |
| Bayer | 7 | $121 |
| Neurelis, Inc. | 6 | $111 |
| UCB, Inc. | 4 | $94 |
| Verona Pharma, Inc. | 5 | $94 |
| Actelion Pharmaceuticals US, Inc. | 1 | $90 |
| Amgen | 4 | $75 |
| Tandem Diabetes Care, Inc. | 3 | $69 |
| Radius Health, Inc. | 2 | $53 |
| Corcept Therapeutics | 2 | $47 |
| Medtronic | 2 | $45 |
| Cequr Corporation | 2 | $43 |
| Exact Sciences | 2 | $42 |
| Merck | 2 | $42 |
| Electromed, Inc. | 1 | $28 |
| Madrigal Pharmaceuticals | 1 | $25 |
| Genentech USA, Inc. | 1 | $25 |
| Johnson & Johnson | 1 | $23 |
| Idorsia Pharmaceuticals US Inc | 1 | $21 |
| Boston Scientific | 1 | $20 |
| Pfizer | 1 | $20 |
| SK Life Science, Inc. | 1 | $20 |
| Recordati_rare_diseases_inc. | 1 | $19 |
| Baxter Healthcare | 1 | $19 |
| Grifols USA, LLC | 1 | $18 |
| ANI Pharmaceuticals, Inc. | 1 | $18 |
| Biogen | 1 | $16 |
| Sequel Med Tech, LLC | 1 | $15 |
| BETA Bionics, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,295 in reported general payments places this provider in the 95th percentile of 487 nurse practitioner providers in Delaware.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 684 | $1,202,060 |
| JardianceEmpagliflozin | 499 | $607,618 |
| TrulicityDulaglutide | 203 | $292,501 |
| RybelsusSemaglutide | 101 | $163,510 |
| MounjaroTirzepatide | 85 | $159,811 |
| FarxigaDapagliflozin Propanediol | 86 | $98,494 |
| Tresiba Flextouch U-200Insulin Degludec | 117 | $95,910 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 130 | $84,946 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 82 | $71,021 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 53 | $61,611 |
| JanuviaSitagliptin Phosphate | 40 | $51,930 |
| Tresiba Flextouch U-100Insulin Degludec | 106 | $51,752 |
| Humalog Kwikpen U-200Insulin Lispro | 34 | $46,865 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 113 | $40,004 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 36 | $37,832 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus, Novolog | $1,537 | $1,372,417803 claims |
| Boehringer IngelheimJardiance, Trijardy Xr, Glyxambi, Tradjenta | $166 | $668,453547 claims |
| Lilly USA, LLCTrulicity, Mounjaro, Humalog | $576 | $458,826303 claims |
| AstraZenecaFarxiga | $170 | $98,49486 claims |
| MerckJanuvia, Janumet | $42 | $73,18964 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $183 | $37,83236 claims |
| Johnson & JohnsonInvokana | $23 | $13,39614 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 487 nurse practitioner providers in Delaware.
Other nurse practitioner in Greenwood
- Meghan McCarterSeaford$170K
- Chandni PatelMiddletown$113K
- Craig LaingMilford$51K
- Colleen DitroWilmington$16K
- Sedelle Henderson-BamideleNewark$13K
- Jennifer HubbardWilmington$12K
- Kathleen HudsonMillville$10K
- Nancy Townsend O'DayMillsboro$8K
- Funmilola OlaoyeNewark$7K
- Monica SamWilmington$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.